Outset Medical Statistics Share Statistics Outset Medical has 17.77M
shares outstanding. The number of shares has increased by 3.57%
in one year.
Shares Outstanding 17.77M Shares Change (YoY) 3.57% Shares Change (QoQ) 0.13% Owned by Institutions (%) 28.3% Shares Floating 16.98M Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.19M, so 12.31% of the outstanding
shares have been sold short.
Short Interest 2.19M Short % of Shares Out 12.31% Short % of Float 12.44% Short Ratio (days to cover) 5.53
Valuation Ratios The PE ratio is -0.45 and the forward
PE ratio is -5.3.
Outset Medical's PEG ratio is
0.02.
PE Ratio -0.45 Forward PE -5.3 PS Ratio 0.51 Forward PS 1.7 PB Ratio 2.15 P/FCF Ratio -0.49 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Outset Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.69,
with a Debt / Equity ratio of 7.53.
Current Ratio 5.69 Quick Ratio 4.38 Debt / Equity 7.53 Debt / EBITDA -2.06 Debt / FCF -1.72 Interest Coverage -4.75
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $321.16K Profits Per Employee $-361.51K Employee Count 354 Asset Turnover 0.41 Inventory Turnover 1.27
Taxes Income Tax 491K Effective Tax Rate -0.39%
Stock Price Statistics The stock price has increased by 74.05% in the
last 52 weeks. The beta is 2.14, so Outset Medical's
price volatility has been higher than the market average.
Beta 2.14 52-Week Price Change 74.05% 50-Day Moving Average 16.39 200-Day Moving Average 14.61 Relative Strength Index (RSI) 39.2 Average Volume (20 Days) 365,538
Income Statement In the last 12 months, Outset Medical had revenue of 113.69M
and earned -127.98M
in profits. Earnings per share was -2.46.
Revenue 113.69M Gross Profit 38.56M Operating Income -113.38M Net Income -127.98M EBITDA -97.89M EBIT -103.61M Earnings Per Share (EPS) -2.46
Full Income Statement Balance Sheet The company has 124.01M in cash and 201.86M in
debt, giving a net cash position of -77.84M.
Cash & Cash Equivalents 124.01M Total Debt 201.86M Net Cash -77.84M Retained Earnings -1.09B Total Assets 288.8M Working Capital 238.67M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -116.3M
and capital expenditures -912K, giving a free cash flow of -117.22M.
Operating Cash Flow -116.3M Capital Expenditures -912K Free Cash Flow -117.22M FCF Per Share -33.84
Full Cash Flow Statement Margins Gross margin is 33.92%, with operating and profit margins of -99.72% and -112.57%.
Gross Margin 33.92% Operating Margin -99.72% Pretax Margin -112.13% Profit Margin -112.57% EBITDA Margin -86.1% EBIT Margin -99.72% FCF Margin -103.1%
Dividends & Yields OM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for OM is $22,
which is 64.8% higher than the current price. The consensus rating is "Hold".
Price Target $22 Price Target Difference 64.8% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 20, 2025. It was a
backward
split with a ratio of 1:15.
Last Split Date Mar 20, 2025 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -3.95 Piotroski F-Score 5
